Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies

Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients

Clinical Applications of Immunotherapy for Recurrent Glioblastoma in Adults

The Viral Knock: Ameliorating Cancer Treatment with Oncolytic Newcastle Disease Virus

Recent oncolytic virotherapy clinical trials outline a roadmap for the treatment of high-grade glioma

Transcriptome Analysis of Natural Killer Cells in Response to Newcastle Disease Virus Infected Hepatocellular Carcinoma Cells

Immune responses elicited by ssRNA(-) oncolytic viruses in the host and in the tumor microenvironment

Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response

Inhibition of Tumor Growth and Metastasis by Newcastle Disease Virus Strain P05 in a Breast Cancer Mouse Model

Tumor cell vaccine combined with Newcastle disease virus promote immunotherapy of lung cancer